Avalo Therapeutics Inc (AVTX:NASDAQ)

$17.64 0.78 (4.63%)

watchlist-icon
search-icon
Profile Icon

This Week's Average Sentiment Analysis Score (0 to 100): 81

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]

Change Analysis Timeline Daily Weekly Monthly

Analysed Avalo Therapeutics Inc (AVTX:NASDAQ) News Sources

Avalo Therapeutics Highlights AVTX-009 HS Phase II Catalyst, Cash Runway at Oppenheimer Conference

Yahoo Finance

external link

Avalo Therapeutics to Participate in Upcoming Investor Conferences

Taiwan News

external link

NanoViricides President Dr. Diwan Interviewed by Mission Matters’ Adam Torres

The Indianapolis Star

external link
AVTX stock
AVTX stock price
AVTX stock price today
AVTX stock prediction
AVTX earnings date
AVTX news
AVTX price
AVTX share
AVTX share price
AVTX shares
AVTX ceo
AVTX premarket
$AVTX
AVTX ticker
AVTX after hours
AVTX stock
AVTX stock price
AVTX stock price today
AVTX stock prediction
AVTX earnings date
AVTX news
AVTX price
AVTX share
AVTX share price
AVTX shares
AVTX ceo
AVTX premarket
$AVTX
AVTX ticker
AVTX after hours

Avalo Therapeutics Inc (AVTX:NASDAQ) FAQs

toggle

What is the current price of Avalo Therapeutics Inc (AVTX:NASDAQ)?

The current price of Avalo Therapeutics Inc (AVTX:NASDAQ) is $17.64.


toggle

Avalo Therapeutics Inc (AVTX:NASDAQ) absolute price change since previous trading day?

The absolute price change of Avalo Therapeutics Inc (AVTX:NASDAQ) since the previous trading day is $0.78.


toggle

Avalo Therapeutics Inc (AVTX:NASDAQ) percentage price change since previous trading day?

The percentage price change of Avalo Therapeutics Inc (AVTX:NASDAQ) since the previous trading day is 4.63%.


toggle

What is This Week's average sentiment score for Avalo Therapeutics Inc (AVTX:NASDAQ)?

This Week's average sentiment score for Avalo Therapeutics Inc (AVTX:NASDAQ) is 81 out of 100.


toggle

What is This Week's average sentiment for Avalo Therapeutics Inc (AVTX:NASDAQ)?

This Week's sentiment for Avalo Therapeutics Inc (AVTX:NASDAQ) is .


Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.